Viewing Study NCT06021366


Ignite Creation Date: 2025-12-24 @ 4:35 PM
Ignite Modification Date: 2026-02-01 @ 11:45 AM
Study NCT ID: NCT06021366
Status: COMPLETED
Last Update Posted: 2023-09-01
First Post: 2023-08-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment Patterns With Brolucizumab in Germany - a Retrospective Cohort Study Based on Longitudinal Prescription Data: REALIZE Study
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neovascular Age-related Macular Degeneration View
Keywords: